Assessment of effectiveness of Empagliflozin in the management of Anemia in diabetes patients
- Conditions
- Health Condition 1: E112- Type 2 diabetes mellitus with kidney complications
- Registration Number
- CTRI/2024/02/063292
- Lead Sponsor
- SRM Insitute of Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Estimated glomerular filtration rate 45 to 90 ml per minute .
Diabetic patients HbA1C greater than 6.5 percent
Patients with haemoglobin less than 13.0 g per dL in males.
Haemoglobin less than 12.0 g per dL in females.
End Stage Renal Disease patients Stage 4
Patients with hereditary iron metabolism disorders.
Patients with Type 1 Diabetes mellitus.
Patients with pre-existing Urinary tract or Genital infections and patients who develop this complication during the study.
Patient with pyelonephritis.
Patients already taking diuretics.
Pregnant and Lactating women.
Treatment with any other investigational drug within the previous 30 days of inclusion in the study.
Any therapy or condition that would pose a risk to the patient or make it difficult to comply with study requirements.
Difficulty in Socio Culture Communication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method